カテゴリ： MarketLine, 中国, 企業調査

China Railway Construction Corporation Ltd：戦略・SWOT・企業財務分析

◆英語タイトル：China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8014817
◆発行会社（調査会社）：MarketLine
◆発行日：2017年11月12日
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：中国
◆産業分野：建設・不動産
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

China Railway Construction Corporation Ltd – Strategy, SWOT and Corporate Finance Report
Summary

China Railway Construction Corporation Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

China Railway Construction Corporation Ltd (CRCC) is a heavy construction contractor. It focuses on the infrastructure construction and undertakes projects railways, bridges, tunnels, roads and highways, bridges, tunnels and airports projects. The company also offers construction services for water conservancy and hydroelectricity facility, ports, industrial and civil construction and municipal projects. In addition, it provides survey, design and consultation services, and manufactures road maintenance machinery and high speed railway switch, springs and rail fasteners. The company also carries out the real estate development, logistics, trading and capital operations. The company has its presence across various provinces in China, Hong Kong and Macau; and other countries. CRCC is headquartered in Beijing, China.

Scope

- Detailed information on China Railway Construction Corporation Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting China Railway Construction Corporation Ltd in the form of a SWOT analysis
- An in-depth view of the business model of China Railway Construction Corporation Ltd including a breakdown and examination of key business segments
- Intelligence on China Railway Construction Corporation Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about China Railway Construction Corporation Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of China Railway Construction Corporation Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess China Railway Construction Corporation Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on China Railway Construction Corporation Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
China Railway Construction Corporation Ltd: Company Overview
China Railway Construction Corporation Ltd: Overview and Key Facts
China Railway Construction Corporation Ltd: Overview
China Railway Construction Corporation Ltd: Key Facts
China Railway Construction Corporation Ltd: Key Employees
China Railway Construction Corporation Ltd: Key Employee Biographies
China Railway Construction Corporation Ltd: Major Products and Services
China Railway Construction Corporation Ltd: Company History
China Railway Construction Corporation Ltd: Management Statement
China Railway Construction Corporation Ltd: Locations and Subsidiaries
China Railway Construction Corporation Ltd: Key Competitors
China Railway Construction Corporation Ltd: Company Analysis
China Railway Construction Corporation Ltd: Business Description
China Railway Construction Corporation Ltd: SWOT Analysis
China Railway Construction Corporation Ltd: SWOT Overview
China Railway Construction Corporation Ltd: Strengths
China Railway Construction Corporation Ltd: Weaknesses
China Railway Construction Corporation Ltd: Opportunities
China Railway Construction Corporation Ltd: Threats
China Railway Construction Corporation Ltd: Corporate Financial Deals Activity
China Railway Construction Corporation Ltd: Financial Deals Overview
China Railway Construction Corporation Ltd: Targets and Partners
China Railway Construction Corporation Ltd: Top Deals 2013 – 2017YTD*
China Railway Construction Corporation Ltd: Advisors
China Railway Construction Corporation Ltd: Top Legal Advisors
China Railway Construction Corporation Ltd: Mergers and Acquisitions
China Railway Construction Corporation Ltd: Capital Raising
China Railway Construction Corporation Ltd: Partnership
China Railway Construction Corporation Ltd: Recent Developments
China Railway Construction Corporation Ltd: News and Events Summary
China Railway Construction Corporation Ltd: Business Expansion
China Railway Construction Corporation Ltd: Contracts
China Railway Construction Corporation Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: China Railway Construction Corporation Ltd: Key Facts
Table 2: China Railway Construction Corporation Ltd: Key Employees
Table 3: China Railway Construction Corporation Ltd: Locations and Subsidiaries
Table 4: China Railway Construction Corporation Ltd: Key Competitors
Table 5: China Railway Construction Corporation Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 6: China Railway Construction Corporation Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: China Railway Construction Corporation Ltd: Targets and Partners
Table 8: China Railway Construction Corporation Ltd: Top Deals 2013 - 2017YTD*
Table 9: China Railway Construction Corporation Ltd: Legal Advisor Ranking by Value (US$m)
Table 10: China Railway Construction Corporation Ltd: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: China Railway Construction Corporation Ltd: M&A Activity by Geography (2013 - YTD*2017)
Table 12: China Railway Construction Corporation Ltd: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 13: China Railway Construction Corporation Ltd: Capital Raising by Deal Type (2013 - YTD*2017)
Table 14: China Railway Construction Corporation Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 15: China Railway Construction Corporation Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 16: China Railway Construction Corporation Ltd: News and Events Summary
Table 17: China Railway Construction Corporation Ltd: Business Expansion
Table 18: China Railway Construction Corporation Ltd: Contracts
Table 19: China Railway Construction Corporation Ltd: Strategy and Operations

★海外企業調査レポート[China Railway Construction Corporation Ltd：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • QRxPharma Ltd：企業の戦略的SWOT分析
    QRxPharma Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • StageZero Life Sciences Ltd (GEN)：企業の財務・戦略的SWOT分析
    Summary StageZero Life Sciences Ltd (StageZero Life Sciences) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of b …
  • Bellerophon Therapeutics Inc (BLPH)：医療機器：M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • American Blue Ribbon Holdings LLC：企業の戦略・SWOT・財務分析
    American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Illumina Inc (ILMN)：医療機器：M&Aディール及び事業提携情報
    Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microar …
  • I Grandi Viaggi Spa：企業の戦略・SWOT・財務分析
    I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report Summary I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Medusa Mining Ltd：企業の戦略・SWOT・財務分析
    Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ariel Corp：企業の戦略的SWOT分析
    Ariel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • PhoenixBio Co Ltd (6190)：製薬・医療：M&Aディール及び事業提携情報
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blo …
  • Okinawa Electric Power Company Incorporated (9511)：企業の財務・戦略的SWOT分析
    Okinawa Electric Power Company Incorporated (9511) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Enercon GmbH-エネルギー分野：企業M&A・提携分析
    Summary Enercon GmbH (Enercon) is a renewable energy equipment company that manufactures and supplies wind energy converters (WEC). It produces components of the WECs including annular generators, inverters, rotor blades, cast components, towers and machine houses. Enercon provides electrical and me …
  • StarTek Inc (SRT)：企業の財務・戦略的SWOT分析
    Summary StarTek Inc (StarTek) is a business process outsourcing company that offers contact center and customer engagement solutions. The company offers service solutions, technology solutions and customer experience suppor. Its service solution provides multi-channel customer interactions across vo …
  • Vedanta Resources Plc：企業の戦略・SWOT・財務分析
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ImCheck Therapeutics SAS：製薬・医療：M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Infineon Technologies AG (IFX)：企業の財務・戦略的SWOT分析
    Infineon Technologies AG (IFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Fortress Biotech Inc (FBIO)：企業の財務・戦略的SWOT分析
    Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • XOMA Corp (XOMA)：企業の財務・戦略的SWOT分析
    XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Oneok Inc (OKE)：企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Glen Dimplex Group：企業の戦略的SWOT分析
    Glen Dimplex Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • GW Pharmaceuticals Plc (GWPH)：製薬・医療：M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆